Daunoxome Solution For Injection 2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

DaunoXome: Solution for injection (2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

LIPOSOMAL DAUNORUBICIN (LIP oh som al daw noe ROO bi sin) is a chemotherapy drug. This medicine is used to treat Kaposi's sarcoma.

In-Depth Information
Select a Medication

DaunoXome 2mg/ml Solution for Injection

NDC: 108850001
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Kaposi's Sarcoma

Sometimes used for but not FDA approved for the following conditions:
Breast Cancer, Acute Myelogenous Leukemia (AML), Multiple Myeloma, Non-Hodgkin's Lymphoma (NHL)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Do not freeze
DaunoXome 2mg/ml Solution for Injection

Reported Side Effects for DaunoXome 2mg/ml Solution for Injection

Brain Infection Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Mucle Tone Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Eye Pain Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Fluid Around The Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Hiccups Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
High Pressure In Lungs Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Enlarged Liver Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Ringing In Ears Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Coughing Up Blood Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Difficulty Swallowing Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Deafness Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Inceased Urination Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Hallucinations Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Loss Of Memory Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Causing To Be Hungry Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Incoordination Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Emotional Lability Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Irregular Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Suddenly Stopped Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Dehydration Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Removal Of Spleen Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Drowsiness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Enlarged Lymph Nodes Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Nighttime Urination Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Melena Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Stomach Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hemorrhoids Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Hot Flashes Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Mouth Ulcers Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Feeling Sick Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Nerve Pain Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Tenesmus Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Injection Site Reaction Incidence:
1.7%*
Severity: SEVERE
Onset: RAPID
Decreased Appetite Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Flushing Incidence:
2.0%*
Severity: SEVERE
Onset: RAPID
Back Pain Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Excessive Sweating Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Stomach Pain Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Depression Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Shortness Of Breath Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Loose Stools Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
5.0%*
Severity: SEVERE
Onset: EARLY
Inability To Sleep Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
6.0%*
Severity: SEVERE
Onset: EARLY
Joint Pain Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
7.0%*
Severity: MILD
Onset: RAPID
Muscle Pain Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
19.0%*
Severity: MILD
Onset: RAPID
Low White Blood Cells Incidence:
36.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
40.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with DaunoXome

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5